Close

Arena's (ARNA) Lorcaserin Becomes First Weight-Loss Drug Approved in 13 Years

June 27, 2012 12:56 PM EDT
With approval, Arena Pharmaceuticals' (Nasdaq: ARNA) lorcaserin (Belviq) becomes first weight-loss drug approved in 13 years. Shares are currently halted.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Insiders' Blog, Trader Talk